​

BeyondSpring (BYSI) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

BYSI Stock Rating

BeyondSpring stock's rating consensus is Buy, based on 8 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (75.00%), 2 Hold (25.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 8 0 2 6 Strong Sell Sell Hold Buy Strong Buy

BYSI Price Target Upside V Benchmarks

TypeNameUpside
StockBeyondSpring-
SectorHealthcare Stocks 23.68%
IndustryBiotech Stocks 64.77%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$2.83$2.83$2.83
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Nov, 24-2---2
Oct, 2412---3
Sep, 2412---3
Aug, 2412---3
Jul, 2411---2
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-1.75$-0.93$-0.54$-0.28--
Avg Forecast$-1.55$-0.70$-0.47$0.25$1.10$1.98
High Forecast$-1.55$-0.70$-0.47$0.25$1.10$1.98
Low Forecast$-1.55$-0.70$-0.47$0.25$1.10$1.98
Surprise %12.90%32.86%14.89%-212.00%--

Revenue Forecast

$0 $40M $80M $120M $160M $200M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$1.35M$1.35M$1.75M---
Avg Forecast$1.27M$1.55M$1.35M$83.68M$137.95M$194.65M
High Forecast$1.27M$1.55M$1.35M$83.68M$137.95M$194.65M
Low Forecast$1.27M$1.55M$1.35M$83.68M$137.95M$194.65M
Surprise %6.66%-12.84%29.61%---

Net Income Forecast

$-100M $-60M $-20M $20M $60M $100M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-68.21M$-36.28M$-21.03M$-11.12M--
Avg Forecast$-60.44M$-27.47M$-18.33M$9.75M$42.90M$77.21M
High Forecast$-60.44M$-27.47M$-18.33M$9.75M$42.90M$77.21M
Low Forecast$-60.44M$-27.47M$-18.33M$9.75M$42.90M$77.21M
Surprise %12.84%32.06%14.72%-214.09%--

BYSI Forecast FAQ

Is BeyondSpring stock a buy?

BeyondSpring stock has a consensus rating of Buy, based on 8 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that BeyondSpring is a favorable investment for most analysts.

What is BeyondSpring's price target?

BeyondSpring's price target, set by 8 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $2.83.

How does BeyondSpring stock forecast compare to its benchmarks?

BeyondSpring's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (23.68%) and underperforming the biotech stocks industry (64.77%).

What is the breakdown of analyst ratings for BeyondSpring over the past three months?

  • November 2024: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • October 2024: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • September 2024: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is BeyondSpring’s EPS forecast?

BeyondSpring's average annual EPS forecast for its fiscal year ending in December 2025 is $1.1, marking a -492.86% decrease from the reported $-0.28 in 2024. Estimates for the following years are.

What is BeyondSpring’s revenue forecast?

BeyondSpring's average annual revenue forecast for its fiscal year ending in December 2025 is $137.95M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for.

What is BeyondSpring’s net income forecast?

BeyondSpring's net income forecast for the fiscal year ending in December 2025 stands at $42.9M, representing a -485.65% decrease from the reported $-11.123M in 2024. Projections indicate .